drugset / Trial / NCT05076032
Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of this clinical research trial is to test the efficacy of OXO-001 in a daily oral administration increasing the pregnancy rate in IVF/ICSI by preparing the uterus to receive the embryo.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2023-08-01
- Completion
- 2023-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OXO-001 | Unknown | 200 mg | Oral |
| Subject | OXO-001 | Unknown | 300 mg | Oral |